Paul Saskin

Efficacy of long-term treatment with daridorexant in patients with insomnia disorder on sleep and daytime functioning: a post-hoc analysis

Abstract: Daridorexant improved night and daytime symptoms of insomnia disorder in two parallel, phase 3, 12-week studies with maintained improvements over a 40-week extension study. The ...

Elaine Liu ;

Paul Saskin ;

01/19/2023

Featured CME Course

Targeted Therapies for the Management of Chronic Lymphocytic Leukemia: Evaluating the Evidence to Optimize Patient Care and Outcomes

Upcoming Events

April 3 ⁠–⁠ April 4

April 5 ⁠–⁠ April 6

April 21 ⁠–⁠ April 24

April 29 ⁠–⁠ April 30

April 30 ⁠–⁠ May 4

May 1 ⁠–⁠ May 2

May 7 ⁠–⁠ May 9

May 8 ⁠–⁠ May 10

May 14 ⁠–⁠ May 16

May 19 ⁠–⁠ May 21

See Full Calendar

Paul Saskin

Featured CME Course

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products